BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 BioNTech (Press Release) 11:50 Tue, 21 Apr
BioNTech and DualityBio report positive data for trastuzumab pamirtecan Hospital Management 11:30 Mon, 13 Apr
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer BioNTech (Press Release) 12:10 Sat, 11 Apr
BioNTech telegraphs closure of Singapore vaccine facility amid efforts to 'align capacity' FiercePharma 19:57 Thu, 02 Apr
BioNTech to close vaccine manufacturing plant in Singapore by 2027 Channel NewsAsia 10:16 Thu, 02 Apr
BioNTech to wind up Singapore vaccine manufacturing plant in early 2027 The Straits Times 13:03 Wed, 01 Apr
BioNTech (NasdaqGS:BNTX) Valuation Check After New Lung Cancer Data Highlights Oncology Pipeline Progress Simply Wall St 09:36 Fri, 27 Mar
